https://stock.noler.com/us/stock/mrna https://stock.noler.com/us/stock/mrna/13f-holdings https://stock.noler.com/us/stock/mrna/accounts-payable https://stock.noler.com/us/stock/mrna/accounts-receivable https://stock.noler.com/us/stock/mrna/accounts-receivable-gross https://stock.noler.com/us/stock/mrna/accounts-receivable-net https://stock.noler.com/us/stock/mrna/accounts-receivable-related-parties-current https://stock.noler.com/us/stock/mrna/accrual-at-carrying-value https://stock.noler.com/us/stock/mrna/accrued-liabilities-current https://stock.noler.com/us/stock/mrna/accrued-royalties-current https://stock.noler.com/us/stock/mrna/accrued-royalties-current-and-noncurrent https://stock.noler.com/us/stock/mrna/accumulated-depreciation https://stock.noler.com/us/stock/mrna/acquisitions https://stock.noler.com/us/stock/mrna/activist-13d-13g https://stock.noler.com/us/stock/mrna/additional-paid-in-capital https://stock.noler.com/us/stock/mrna/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/mrna/advertising-expense https://stock.noler.com/us/stock/mrna/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/mrna/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/mrna/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/mrna/amended-reports-10-k https://stock.noler.com/us/stock/mrna/analyst-ratings-buy https://stock.noler.com/us/stock/mrna/analyst-ratings-hold https://stock.noler.com/us/stock/mrna/analyst-ratings-no-rating https://stock.noler.com/us/stock/mrna/analyst-ratings-sell https://stock.noler.com/us/stock/mrna/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/mrna/aoci https://stock.noler.com/us/stock/mrna/asset-impairment-charges https://stock.noler.com/us/stock/mrna/auditor https://stock.noler.com/us/stock/mrna/available-for-sale-debt-allowance-for-credit-loss https://stock.noler.com/us/stock/mrna/available-for-sale-debt-allowance-for-credit-loss-not-previously-recorded https://stock.noler.com/us/stock/mrna/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/mrna/available-for-sale-debt-current https://stock.noler.com/us/stock/mrna/available-for-sale-debt-maturities-after-one-through-five-years-amortized-cost https://stock.noler.com/us/stock/mrna/available-for-sale-debt-maturities-after-one-through-five-years-fair-value https://stock.noler.com/us/stock/mrna/available-for-sale-debt-maturities-single-maturity-date https://stock.noler.com/us/stock/mrna/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/mrna/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/mrna/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/mrna/available-for-sale-debt-unrealized-loss-position https://stock.noler.com/us/stock/mrna/available-for-sale-debt-unrealized-loss-position-12-months-or-longer https://stock.noler.com/us/stock/mrna/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-loss https://stock.noler.com/us/stock/mrna/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-number-of-positions https://stock.noler.com/us/stock/mrna/available-for-sale-debt-unrealized-loss-position-less-than-12-months https://stock.noler.com/us/stock/mrna/available-for-sale-debt-unrealized-loss-position-less-than-12-months-loss https://stock.noler.com/us/stock/mrna/available-for-sale-debt-unrealized-loss-position-loss https://stock.noler.com/us/stock/mrna/available-for-sale-debt-unrealized-loss-position-number-of-positions https://stock.noler.com/us/stock/mrna/basic-shares https://stock.noler.com/us/stock/mrna/business https://stock.noler.com/us/stock/mrna/buyback-authorization https://stock.noler.com/us/stock/mrna/buyback-authorization-remaining https://stock.noler.com/us/stock/mrna/buybacks-payments-for-repurchase-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/mrna/buybacks-share-repurchases https://stock.noler.com/us/stock/mrna/buybacks-shares-repurchased https://stock.noler.com/us/stock/mrna/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/mrna/buybacks-treasury-shares-acquired https://stock.noler.com/us/stock/mrna/capital-expenditures https://stock.noler.com/us/stock/mrna/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/mrna/capital-lease-obligations https://stock.noler.com/us/stock/mrna/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/mrna/cash-and-equivalents https://stock.noler.com/us/stock/mrna/cash-and-restricted-cash https://stock.noler.com/us/stock/mrna/cash-flow-breakdown https://stock.noler.com/us/stock/mrna/clinical-trials https://stock.noler.com/us/stock/mrna/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/mrna/common-stock-value https://stock.noler.com/us/stock/mrna/company-guidance https://stock.noler.com/us/stock/mrna/company-profile https://stock.noler.com/us/stock/mrna/comprehensive-income https://stock.noler.com/us/stock/mrna/congressional-trades-stocks-including-adrs https://stock.noler.com/us/stock/mrna/contract-liability https://stock.noler.com/us/stock/mrna/contract-with-customer-asset-net https://stock.noler.com/us/stock/mrna/contract-with-customer-liability-cumulative-catch-up-adjustment-to-revenue-change-in-estimate-of-transaction-price https://stock.noler.com/us/stock/mrna/contract-with-customer-liability-cumulative-catch-up-adjustment-to-revenue-change-in-measure-of-progress https://stock.noler.com/us/stock/mrna/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/mrna/contract-with-customer-refund-liability https://stock.noler.com/us/stock/mrna/convertible-securities-retired https://stock.noler.com/us/stock/mrna/cost-of-revenue https://stock.noler.com/us/stock/mrna/costs-and-expenses https://stock.noler.com/us/stock/mrna/cover-page-shares-outstanding https://stock.noler.com/us/stock/mrna/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/mrna/current-assets https://stock.noler.com/us/stock/mrna/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/mrna/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/mrna/current-income-tax-expense-benefit https://stock.noler.com/us/stock/mrna/current-liabilities https://stock.noler.com/us/stock/mrna/current-ratio https://stock.noler.com/us/stock/mrna/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/mrna/debt-equity-ratio https://stock.noler.com/us/stock/mrna/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/mrna/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/mrna/deferred-income-tax-assets-net https://stock.noler.com/us/stock/mrna/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/mrna/deferred-income-tax-liabilities https://stock.noler.com/us/stock/mrna/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/mrna/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/mrna/deferred-revenue https://stock.noler.com/us/stock/mrna/deferred-revenue-noncurrent https://stock.noler.com/us/stock/mrna/deferred-revenue-recognized https://stock.noler.com/us/stock/mrna/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/mrna/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/mrna/deferred-tax-assets-gross https://stock.noler.com/us/stock/mrna/deferred-tax-assets-inventory https://stock.noler.com/us/stock/mrna/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/mrna/deferred-tax-assets-net https://stock.noler.com/us/stock/mrna/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/mrna/deferred-tax-assets-other https://stock.noler.com/us/stock/mrna/deferred-tax-assets-other-comprehensive-loss https://stock.noler.com/us/stock/mrna/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/mrna/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/mrna/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/mrna/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-returns-and-allowances https://stock.noler.com/us/stock/mrna/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/mrna/deferred-tax-liabilities-other https://stock.noler.com/us/stock/mrna/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/mrna/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/mrna/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/mrna/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/mrna/depreciation-and-amortization https://stock.noler.com/us/stock/mrna/derivative-assets https://stock.noler.com/us/stock/mrna/derivative-assets-current https://stock.noler.com/us/stock/mrna/derivative-liabilities https://stock.noler.com/us/stock/mrna/derivative-notional-amount https://stock.noler.com/us/stock/mrna/diluted-shares https://stock.noler.com/us/stock/mrna/dilutive-shares https://stock.noler.com/us/stock/mrna/distribution-made-to-limited-liability-company-llc-member-cash-distributions-paid https://stock.noler.com/us/stock/mrna/dividend https://stock.noler.com/us/stock/mrna/dividend-safety https://stock.noler.com/us/stock/mrna/dividends-declared https://stock.noler.com/us/stock/mrna/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/mrna/ebitda https://stock.noler.com/us/stock/mrna/ebitda-margin https://stock.noler.com/us/stock/mrna/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/mrna/effective-tax-rate https://stock.noler.com/us/stock/mrna/employee-count https://stock.noler.com/us/stock/mrna/employee-related-liabilities-current https://stock.noler.com/us/stock/mrna/eps https://stock.noler.com/us/stock/mrna/eps-basic https://stock.noler.com/us/stock/mrna/equity-method-investments https://stock.noler.com/us/stock/mrna/equity-securities-fv-ni-realized-gain-loss https://stock.noler.com/us/stock/mrna/equity-securities-without-readily-determinable-fair-value-amount https://stock.noler.com/us/stock/mrna/estimate-of-possible-loss https://stock.noler.com/us/stock/mrna/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/mrna/executive-pay-pvp https://stock.noler.com/us/stock/mrna/executive-salary-officers https://stock.noler.com/us/stock/mrna/expense-breakdown https://stock.noler.com/us/stock/mrna/finance-lease-interest-expense https://stock.noler.com/us/stock/mrna/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/mrna/finance-lease-liability https://stock.noler.com/us/stock/mrna/finance-lease-liability-current https://stock.noler.com/us/stock/mrna/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due-after-year-five https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due-in-next-rolling-twelve-months https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due-in-rolling-after-year-five https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due-in-rolling-year-five https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due-in-rolling-year-four https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/mrna/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/mrna/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/mrna/finance-lease-principal-payments https://stock.noler.com/us/stock/mrna/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/mrna/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/mrna/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/mrna/financing-cash-flow https://stock.noler.com/us/stock/mrna/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/mrna/foreign-currency-cash-flow-hedge-gain-loss-to-be-reclassified-during-next-12-months https://stock.noler.com/us/stock/mrna/foreign-pretax-income https://stock.noler.com/us/stock/mrna/form-144-stocks https://stock.noler.com/us/stock/mrna/form-n-port-stocks https://stock.noler.com/us/stock/mrna/gain-loss-on-sale-of-leased-assets-net-operating-leases https://stock.noler.com/us/stock/mrna/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/mrna/general-and-administrative-expense https://stock.noler.com/us/stock/mrna/goodwill https://stock.noler.com/us/stock/mrna/grants-receivable-current https://stock.noler.com/us/stock/mrna/graph https://stock.noler.com/us/stock/mrna/gross-margin https://stock.noler.com/us/stock/mrna/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/mrna/included-in-etf https://stock.noler.com/us/stock/mrna/income-loss-from-equity-method-investments-net-of-dividends-or-distributions https://stock.noler.com/us/stock/mrna/income-tax https://stock.noler.com/us/stock/mrna/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/mrna/income-taxes-paid https://stock.noler.com/us/stock/mrna/income-taxes-receivable https://stock.noler.com/us/stock/mrna/income-taxes-receivable-noncurrent https://stock.noler.com/us/stock/mrna/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/mrna/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/mrna/increase-decrease-in-accounts-receivable-related-parties https://stock.noler.com/us/stock/mrna/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/mrna/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/mrna/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/mrna/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/mrna/increase-decrease-in-inventories https://stock.noler.com/us/stock/mrna/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/mrna/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/mrna/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/mrna/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/mrna/insider-transactions https://stock.noler.com/us/stock/mrna/interest-paid-net https://stock.noler.com/us/stock/mrna/interest-receivable-current https://stock.noler.com/us/stock/mrna/inventory https://stock.noler.com/us/stock/mrna/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/mrna/inventory-firm-purchase-commitment-loss https://stock.noler.com/us/stock/mrna/inventory-gross https://stock.noler.com/us/stock/mrna/inventory-noncurrent https://stock.noler.com/us/stock/mrna/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/mrna/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/mrna/inventory-write-down https://stock.noler.com/us/stock/mrna/investing-cash-flow https://stock.noler.com/us/stock/mrna/investment-income-interest https://stock.noler.com/us/stock/mrna/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/mrna/iran-activity-notices-irannotice https://stock.noler.com/us/stock/mrna/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/mrna/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/mrna/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/mrna/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/mrna/lines-of-credit-fair-value-disclosure https://stock.noler.com/us/stock/mrna/long-term-debt https://stock.noler.com/us/stock/mrna/market-cap https://stock.noler.com/us/stock/mrna/material-contracts https://stock.noler.com/us/stock/mrna/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/mrna/net-change-in-cash https://stock.noler.com/us/stock/mrna/net-income https://stock.noler.com/us/stock/mrna/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/mrna/net-margin https://stock.noler.com/us/stock/mrna/news https://stock.noler.com/us/stock/mrna/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/mrna/number-of-operating-segments https://stock.noler.com/us/stock/mrna/number-of-reportable-segments https://stock.noler.com/us/stock/mrna/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/mrna/oci-cash-flow-hedge-gain-loss-after-reclassification-and-tax https://stock.noler.com/us/stock/mrna/oci-cash-flow-hedge-gain-loss-after-reclassification-and-tax-parent https://stock.noler.com/us/stock/mrna/oci-cash-flow-hedge-gain-loss-before-reclassification-after-tax https://stock.noler.com/us/stock/mrna/oci-cash-flow-hedge-gain-loss-reclassification-after-tax https://stock.noler.com/us/stock/mrna/oci-defined-benefit-plans-adjustment-net-of-tax https://stock.noler.com/us/stock/mrna/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/mrna/oci-net-of-tax https://stock.noler.com/us/stock/mrna/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/mrna/oci-reclassification-adjustment-from-aoci-pension-and-other-postretirement-benefit-plans-net-of-tax https://stock.noler.com/us/stock/mrna/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/mrna/oci-unrealized-holding-gain-loss-on-securities-arising-tax https://stock.noler.com/us/stock/mrna/operating-cash-flow https://stock.noler.com/us/stock/mrna/operating-expenses https://stock.noler.com/us/stock/mrna/operating-income https://stock.noler.com/us/stock/mrna/operating-lease-assets https://stock.noler.com/us/stock/mrna/operating-lease-cost https://stock.noler.com/us/stock/mrna/operating-lease-liability https://stock.noler.com/us/stock/mrna/operating-lease-liability-current https://stock.noler.com/us/stock/mrna/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/mrna/operating-lease-payments https://stock.noler.com/us/stock/mrna/operating-lease-payments-due https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-2 https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-after-rolling-year-five https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-current https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-in-rolling-year-five https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-in-rolling-year-four https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-next-rolling-twelve-months https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/mrna/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/mrna/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/mrna/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/mrna/operating-leases-rent-expense-net https://stock.noler.com/us/stock/mrna/operating-margin https://stock.noler.com/us/stock/mrna/options-activity https://stock.noler.com/us/stock/mrna/other-accrued-liabilities-current https://stock.noler.com/us/stock/mrna/other-assets-miscellaneous-noncurrent https://stock.noler.com/us/stock/mrna/other-current-assets https://stock.noler.com/us/stock/mrna/other-current-liabilities https://stock.noler.com/us/stock/mrna/other-depreciation-and-amortization https://stock.noler.com/us/stock/mrna/other-inventory-capitalized-costs https://stock.noler.com/us/stock/mrna/other-noncash-income-expense https://stock.noler.com/us/stock/mrna/other-noncurrent-assets https://stock.noler.com/us/stock/mrna/other-noncurrent-liabilities https://stock.noler.com/us/stock/mrna/other-nonoperating-income-expense https://stock.noler.com/us/stock/mrna/other-prepaid-expense-current https://stock.noler.com/us/stock/mrna/other-sundry-liabilities-current https://stock.noler.com/us/stock/mrna/other-sundry-liabilities-noncurrent https://stock.noler.com/us/stock/mrna/other-than-temporary-impairment-loss-available-for-sale-debt-recognized-in-earnings https://stock.noler.com/us/stock/mrna/outstanding-bonds https://stock.noler.com/us/stock/mrna/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/mrna/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/mrna/patents-active https://stock.noler.com/us/stock/mrna/payments-of-capital-distribution https://stock.noler.com/us/stock/mrna/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/mrna/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/mrna/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/mrna/payments-to-acquire-in-process-research-and-development https://stock.noler.com/us/stock/mrna/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/mrna/payments-to-acquire-notes-receivable https://stock.noler.com/us/stock/mrna/pb-ratio https://stock.noler.com/us/stock/mrna/pe-ratio https://stock.noler.com/us/stock/mrna/pre-tax-margin https://stock.noler.com/us/stock/mrna/preferred-shares-facts https://stock.noler.com/us/stock/mrna/preferred-stock-accretion-of-redemption-discount https://stock.noler.com/us/stock/mrna/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/mrna/preferred-stock-redemption-premium https://stock.noler.com/us/stock/mrna/preferred-stock-shares-authorized https://stock.noler.com/us/stock/mrna/preferred-stock-shares-issued https://stock.noler.com/us/stock/mrna/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/mrna/preferred-stock-value https://stock.noler.com/us/stock/mrna/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/mrna/prepaid-expense-current https://stock.noler.com/us/stock/mrna/prepaid-taxes https://stock.noler.com/us/stock/mrna/pretax-income https://stock.noler.com/us/stock/mrna/pretax-income-domestic https://stock.noler.com/us/stock/mrna/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/mrna/previous-etf-holding-it https://stock.noler.com/us/stock/mrna/price-fcf-ratio https://stock.noler.com/us/stock/mrna/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/mrna/proceeds-from-issuance-of-redeemable-convertible-preferred-stock https://stock.noler.com/us/stock/mrna/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/mrna/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/mrna/proceeds-from-repayment-of-loans-by-employee-stock-ownership-plans https://stock.noler.com/us/stock/mrna/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/mrna/proceeds-from-stock-issued https://stock.noler.com/us/stock/mrna/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/mrna/proceeds-from-stock-plans https://stock.noler.com/us/stock/mrna/profit-breakdown https://stock.noler.com/us/stock/mrna/property-plant-and-equipment-and-finance-lease-right-of-use-asset-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/mrna/property-plant-and-equipment-and-finance-lease-right-of-use-asset-after-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/mrna/property-plant-and-equipment-and-finance-lease-right-of-use-asset-before-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/mrna/property-plant-and-equipment-gross https://stock.noler.com/us/stock/mrna/property-plant-equipment https://stock.noler.com/us/stock/mrna/property-subject-to-or-available-for-operating-lease-number-of-units https://stock.noler.com/us/stock/mrna/provision-for-doubtful-accounts https://stock.noler.com/us/stock/mrna/ps-ratio https://stock.noler.com/us/stock/mrna/public-float https://stock.noler.com/us/stock/mrna/quick-ratio https://stock.noler.com/us/stock/mrna/reclassifications-of-temporary-to-permanent-equity https://stock.noler.com/us/stock/mrna/redeemable-preferred-stock-dividends https://stock.noler.com/us/stock/mrna/research-and-development https://stock.noler.com/us/stock/mrna/restricted-cash https://stock.noler.com/us/stock/mrna/restricted-cash-current https://stock.noler.com/us/stock/mrna/restricted-cash-noncurrent https://stock.noler.com/us/stock/mrna/restricted-stock-expense https://stock.noler.com/us/stock/mrna/retained-earnings https://stock.noler.com/us/stock/mrna/return-on-tangible-equity https://stock.noler.com/us/stock/mrna/revenue https://stock.noler.com/us/stock/mrna/revenue-breakdown https://stock.noler.com/us/stock/mrna/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/mrna/revenues https://stock.noler.com/us/stock/mrna/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/mrna/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/mrna/roa https://stock.noler.com/us/stock/mrna/roe https://stock.noler.com/us/stock/mrna/roi https://stock.noler.com/us/stock/mrna/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/mrna/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/mrna/sale-of-stock-price-per-share https://stock.noler.com/us/stock/mrna/scorecard https://stock.noler.com/us/stock/mrna/sec-comment-letters-upload https://stock.noler.com/us/stock/mrna/sec-enforcement-actions https://stock.noler.com/us/stock/mrna/sec-filings-10-q https://stock.noler.com/us/stock/mrna/sec-filings-25-nse https://stock.noler.com/us/stock/mrna/sec-filings-8-k https://stock.noler.com/us/stock/mrna/sec-filings-px14a6g https://stock.noler.com/us/stock/mrna/sec-filings-s-4 https://stock.noler.com/us/stock/mrna/secondary-offerings https://stock.noler.com/us/stock/mrna/shareholders-equity https://stock.noler.com/us/stock/mrna/shares-authorized https://stock.noler.com/us/stock/mrna/shares-issued https://stock.noler.com/us/stock/mrna/shares-outstanding https://stock.noler.com/us/stock/mrna/short-sale-volume https://stock.noler.com/us/stock/mrna/short-term-lease-cost https://stock.noler.com/us/stock/mrna/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/mrna/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/mrna/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/mrna/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/mrna/stock-based-compensation https://stock.noler.com/us/stock/mrna/stock-compensation-tax-benefit-from-exercise-of-stock-options https://stock.noler.com/us/stock/mrna/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/mrna/stock-issued-new-shares-sold https://stock.noler.com/us/stock/mrna/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/mrna/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/mrna/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/mrna/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/mrna/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/mrna/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/mrna/stock-options-exercisable-number https://stock.noler.com/us/stock/mrna/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/mrna/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/mrna/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/mrna/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/mrna/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/mrna/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/mrna/stock-options-outstanding-number https://stock.noler.com/us/stock/mrna/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/mrna/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/mrna/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/mrna/stock-split-ratio https://stock.noler.com/us/stock/mrna/stock-splits https://stock.noler.com/us/stock/mrna/subsidiaries https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-fdii-percent https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-percent https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-tax-credits-other https://stock.noler.com/us/stock/mrna/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/mrna/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/mrna/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/mrna/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/mrna/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/mrna/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/mrna/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/mrna/tax-reconciliation-tax-contingencies https://stock.noler.com/us/stock/mrna/tax-reconciliation-tax-credits-other https://stock.noler.com/us/stock/mrna/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/mrna/taxes-payable-current https://stock.noler.com/us/stock/mrna/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/mrna/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/mrna/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/mrna/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/mrna/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/mrna/temporary-equity-shares-authorized https://stock.noler.com/us/stock/mrna/temporary-equity-shares-issued https://stock.noler.com/us/stock/mrna/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/mrna/total-assets https://stock.noler.com/us/stock/mrna/total-contract-liability https://stock.noler.com/us/stock/mrna/total-liabilities https://stock.noler.com/us/stock/mrna/total-liabilities-and-equity https://stock.noler.com/us/stock/mrna/treasury-stock-acquired-average-cost-per-share https://stock.noler.com/us/stock/mrna/treasury-stock-retired-cost-method-amount https://stock.noler.com/us/stock/mrna/unrecognized-tax-benefits https://stock.noler.com/us/stock/mrna/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/mrna/utb-decrease-from-settlements https://stock.noler.com/us/stock/mrna/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/mrna/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/mrna/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/mrna/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/mrna/value-added-tax-receivable-current https://stock.noler.com/us/stock/mrna/variable-lease-cost https://stock.noler.com/us/stock/mrna/weighted-average-number-of-share-outstanding-basic-and-diluted